menu ☰
menu ˟

Spark acquires Genable Technologies

07 Mar 2016
Spark Therapeutics has acquired Genable Technologies, a gene therapy company based in Dublin, Ireland, according to a press release. Under the acquisition, Spark paid $6 million in cash and 265,000 shares of Spark common stock to Genable shareholders...

Click here to view the full article which appeared in Opthalmology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.